Hilltop National Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170K Sell
1,342
-220
-14% -$29K 0.04% 272
2026
Q1
$218K Buy
1,562
+262
+20% +$36.7K 0.05% 221
2025
Q4
$160K Buy
1,300
+522
+67% +$63.4K 0.04% 260
2025
Q3
$86.4K Hold
778
0.02% 374
2025
Q2
$86.3K Buy
+778
New +$82.8K 0.02% 368
2024
Q4
$37.1K Hold
402
0.01% 483
2024
Q3
$33.7K Sell
402
-460
-53% -$35.1K 0.01% 518
2024
Q2
$59.1K Hold
862
0.02% 425
2024
Q1
$63.1K Buy
+862
New +$66.3K 0.02% 408

Other funds holding GILD

Hilltop National Bank's GILD Position: Q2 2026 in Review

Hilltop National Bank reduced its Gilead Sciences (GILD) stake by 14% in Q2 2026, selling an estimated $29K and leaving 1,342 shares worth $170K. The position accounts for 0.04% of the portfolio, ranked #272.

Hilltop National Bank first reported a position in GILD in Q1 2024 and has held it in 9 quarters since. The position peaked at $218K in Q1 2026. 758 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hilltop National Bank held 1,342 shares of Gilead Sciences worth $170K as of Q2 2026.
  • Hilltop National Bank sold 220 Gilead Sciences shares in Q2 2026, an estimated $29K.
  • Gilead Sciences made up 0.04% of Hilltop National Bank's portfolio in Q2 2026, its #272 holding.
  • Hilltop National Bank first reported a position in Gilead Sciences in Q1 2024 and has held it in 9 quarters since.
  • Hilltop National Bank's Gilead Sciences position peaked at $218K in Q1 2026.
  • 758 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.